ENOV vs. ORIC

Last updated Aug 4, 2026

ENOV (Enovis Corp) and ORIC (ORIC Pharmaceuticals, Inc.) are both stocks. ENOV operates in Specialty Industrial Machinery (Industrials), while ORIC operates in Biotechnology (Healthcare). Over the past 5 years, ENOV returned -16.83%/yr vs -7.79%/yr for ORIC. Their 0.19 correlation means their historical movements had little consistent relationship.

Performance

ENOV vs. ORIC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enovis Corp (ENOV) and ORIC Pharmaceuticals, Inc. (ORIC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ENOV achieves a 17.94% return, which is significantly lower than ORIC's 29.58% return.

ENOV

• 1D: 7.79%
• 1M: 39.64%
• 6M: 41.72%
• YTD: 17.94%
• 1Y: 22.07%
• 3Y*: -19.05%
• 5Y*: -16.83%
• 10Y*: -4.77%
• ALL TIME*: -1.26%

ORIC

• 1D: -4.25%
• 1M: -8.93%
• 6M: -5.02%
• YTD: 29.58%
• 1Y: 4.74%
• 3Y*: 11.39%
• 5Y*: -7.79%
• 10Y*: —
• ALL TIME*: -13.32%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ENOV Enovis Corp	$27.31M	$29.09M	$28.88M
ORIC ORIC Pharmaceuticals, Inc.	$20.95M	$18.52M	$16.09M

ENOV vs. ORIC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
ENOV Enovis Corp	17.94%	-39.29%	-21.67%	4.67%	-32.36%	20.21%	63.28%
ORIC ORIC Pharmaceuticals, Inc.	29.58%	1.36%	-12.28%	56.20%	-59.93%	-56.57%	30.19%

Correlation

The correlation between ENOV and ORIC is 0.05, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.05
Correlation (3Y) Balances recent behavior with more history.	0.19
Correlation (5Y) Shows whether the relationship held over a longer period.	0.22
Correlation (All Time) Calculated using the full available price history since Apr 24, 2020	0.19

The correlation between ENOV and ORIC shifts across timeframes, from 0.05 (1 year) to 0.22 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ENOV : $1.81B ORIC : $1.10B
EPS ENOV : -$30.04 ORIC : -$1.40
Total Revenue (TTM) ENOV : $2.28B ORIC : $0.00
Gross Profit (TTM) ENOV : $1.38B ORIC : -$320.00K
EBITDA (TTM) ENOV : -$840.37M ORIC : -$143.28M

Return for Risk

ENOV vs. ORIC — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ENOV

ENOV Risk / Return Rank: 56
ENOV Sharpe Ratio Rank: 57
ENOV Sortino Ratio Rank: 56
ENOV Omega Ratio Rank: 54
ENOV Calmar Ratio Rank: 57
ENOV Martin Ratio Rank: 55

ORIC

ORIC Risk / Return Rank: 48
ORIC Sharpe Ratio Rank: 46
ORIC Sortino Ratio Rank: 50
ORIC Omega Ratio Rank: 53
ORIC Calmar Ratio Rank: 46
ORIC Martin Ratio Rank: 45

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ENOV vs. ORIC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enovis Corp (ENOV) and ORIC Pharmaceuticals, Inc. (ORIC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ENOV	ORIC	Difference
Sharpe ratio: Return per unit of total volatility	0.38	0.06	+0.32
Sortino ratio: Return per unit of downside risk	0.97	0.69	+0.28
Omega ratio: Gain probability vs. loss probability	1.11	1.10	+0.01
Calmar ratio: Return relative to maximum drawdown	0.56	0.10	+0.46
Martin ratio: Return relative to average drawdown	0.97	0.18	+0.79

ENOV vs. ORIC - Sharpe Ratio Comparison

The current ENOV Sharpe Ratio is 0.38, which is higher than the ORIC Sharpe Ratio of 0.06. The chart below compares the historical Sharpe Ratios of ENOV and ORIC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ENOV vs. ORIC - Drawdown Comparison

The maximum ENOV drawdown since its inception was -84.46%, smaller than the maximum ORIC drawdown of -93.87%. Use the drawdown chart below to compare losses from any high point for ENOV and ORIC.

Drawdown Indicators

	ENOV	ORIC	Difference
Max Drawdown Largest peak-to-trough decline	-84.46%	-93.87%	+9.41%
Max Drawdown (1Y) Largest decline over 1 year	-39.86%	-48.13%	+8.27%
Max Drawdown (3Y) Largest decline over 3 years	-68.59%	-73.46%	+4.87%
Max Drawdown (5Y) Largest decline over 5 years	-78.02%	-90.33%	+12.31%
Max Drawdown (10Y) Largest decline over 10 years	-78.02%	—	—
Current Drawdown Current decline from peak	-75.63%	-73.37%	-2.26%
Average Drawdown Average peak-to-trough decline	-46.23%	-67.88%	+21.65%
Ulcer Index Depth and duration of drawdowns from previous peaks	22.70%	25.99%	-3.29%

Volatility

ENOV vs. ORIC - Volatility Comparison

Enovis Corp (ENOV) has a higher volatility of 23.89% compared to ORIC Pharmaceuticals, Inc. (ORIC) at 18.27%. This indicates that ENOV's price experiences larger fluctuations and is considered to be riskier than ORIC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ENOV	ORIC	Difference
Volatility (1M) Calculated over the trailing 1-month period	23.89%	18.27%	+5.62%
Volatility (6M) Calculated over the trailing 6-month period	46.82%	75.09%	-28.27%
Volatility (1Y) Calculated over the trailing 1-year period	59.07%	81.84%	-22.77%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	41.06%	90.07%	-49.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	43.15%	87.57%	-44.42%

Dividends

ENOV vs. ORIC - Dividend Comparison

Neither ENOV nor ORIC has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ENOV and ORIC in my portfolio?

ENOV and ORIC have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ENOV or ORIC?

ENOV has higher volatility (23.89%) compared to ORIC (18.27%). In terms of maximum drawdown, ENOV dropped -84.46% vs ORIC's -93.87%.

Which has better risk-adjusted returns?

ENOV currently has the higher Sharpe Ratio (0.38 vs 0.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.